ArticleBioMed research international2015

miR-155 and miR-484 Are Associated with Time to Progression in Metastatic Renal Cell Carcinoma Treated with Sunitinib.

Jana Merhautova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.